update

drug

TG Therapeutics Inc

trading

Unbelievable how negative this stock trades against bio stocks with not much going on besides mediocre trials.

Big Loser Alert: Trading today&#39;s -7.2% move in TG THERAPEUTICS $TGTX https://wp.me/p5bLGB-iva5

↳ Why are you paying to be in a Trading Room?

action

$TGTX stock action negative this whole week.

$TGTX we&#39;re missing something here, the price action is a bit worrisome.

This price action is pathetic after holding this bag for years.

life

manipulation

It&#39;s eye opening to see the blatant manipulation.

$TGTX no real sellers here, all fake manipulation

Screw off $GS   hope they get crushed from the sec for stock manipulation  I can’t stand these fools.

Practically the only thing red today… lame 😒

$TGTX $19.00 in the red 😎 this thing sends chills down my arms.

SAFEST &amp; CHEAPEST MS DRUG ON THE PLANET .

No cases of PML

- Highest efficacy of the 4 leading MS drugs

It bottomed in December at $0.55 and has since risen 300% on practically no news other than them having funding until 3Q23 and their primary pipeline item being an epilepsy drug currently in Phase 2.

we will join them with best drug in class.

This is the better compared to all other RMS drugs out there.

.. as a safer alternative to current MS drugs.

We  have  the  best  in  class  drug  with  a  clean  label.

hold

$TGTX Worthwhile hold and in time will be quite profitable.

$TGTX Please hold your shares or buy more on the dip You will be very pleased with the outcome

$TGTX good day Bulls, just hold for the gold!! !

This will be huge, and the sp for BO will be massive in 2yrs if they hold out. 100+

Buy, Accumulate, Hold…it’s common sense.

$TGTX &gt; STRONG BUY = BUY/HOLD/ACCUMULATE.

market

Chartwise,  i  would think  this  is   pretty bullish;  given  crap  market. Thoughts?

$TGTX This is the rocky Biden market u all wanted.

Remember that we are ultimately at the beginning of commercialization and quite possible the safest spot to be with the current facts on our superior Briumvi treatment and best pricing for market share penetration.

$TGTX market is doing good, we doing good

$TGTX Looking strong today despite the market.

TG&#39;s Briumvi is positioned to take market share because of these advantages, including how much better it is than all other competitors.

$TGTX  
I found this on NewsBreak: The stock market is on the verge of a rare bullish trifecta that suggests big upside ahead  
https://share.newsbreak.com/2tuqqt3a

I have done plenty of research lately on the market TAM and this looks primed to move quickly once it gets rolling.

$TGTX Up 23% from the lows of pre market 3 trading days ago.

Hepion Pharmaceuticals Inc

hand

10% of the float is in institutional index funds hands and that is shite.

In the last 2 years many weak hands have lost money selling for desperation..We are all  Screwed since we were part of a well organized fraudulent plan.

Won’t give them another dollar from my hand earned money…

Where you  perhaps you planned to spend what time you have might , if you are caught , just slip out of your hands !

short

The naked shorters are starting to feel the cactus being slowly shoved up their asses.

$HEPA $CVNA Shorts in big trouble in both these tickers

$HEPA shorties better cover!! 🤦🏼‍♂️🤦🏼‍♂️🤡🤡😂😂😂

$HEPA it seems like shorts got caught naked.

Sit there bitching and complaining about shorts.

Shorts are trapped and face more issues as share prices continues rising.

shit

$HEPA Can someone please explain to me why longs keep torturing themselves day after day by holding on to this crap?

$HEPA MMs using six decimals is effing bullshit!

$HEPA Official update from all time low close of .27 on 12/28: Over the course of 11 trading days, we are up 250%.

$HEPA Was hoping we would get an update  on our (Nash) trial soon and we got this surprising good news.

We knows recession is coming next year 
4) XBI has bottomed  and should begin its upward move next year 
5) Phase 2b trial results and updates on HCC trial 
6) Probable approvals of NASH drugs and increased bullish sentiment in the sector

The only thing im sure about with this company is that its drug has great potential

This makes Rencofilstat a promising candidate for the treatment of a variety of diseases, including thromboembolic disorders, sepsis, and cancer.

if this is truly a 4B, 5B or more mkt cap drug it’ll ultimately end up with a SP in the hundreds of dollars (assuming RS goes through) and everyone will be happy in the long run.

Despite everything, the fact remains that absolutely nobody has come up with anything substantially bad to report about this amazing drug.

For any investor, being able to buy the company below cash value while getting the wonder drug, Rencofilstat, for free is a VERY attractive investment proposition.

That drug has been proven to be safe to be used in tandem with any other known drugs.

$HEPA this drug is game changer in hepatology!

2023 is going to be highlighted with a continuous cascade of amazingly positive PR’s confirming the fact (already documented in 300+ early clinical studies), that Rencofilstat is truly a Wonder Drug to be celebrated, with an extraordinarily large TAM.

news

$HEPA the consolidation over last weeks is bullish … one day it will explode above 0,88$ or maybe with Gap Up after news … the day is near , Szenario destroyed &lt; 0,66$

The news for $NVS and $PLRX closing their relationship in NASh is good for $HEPA, in my opinion.

prepare for the positive news they know is coming.

The good news is that this stock can be manipulated both ways.

$HEPA 20 something percent haircut over a great news.

$HEPA @BioTuesdays good to see bioTuesday has so much great HEPA news to put out that they have to release some of it on Wednesday ! 🤣

My recommendation is to trust the science and say Buy! Buy!

$HEPA Big nice buy orders being executed. @.

$HEPA this is an extreme buy and HOLD- no one should be selling a share

$HEPA Hold enjoy the ride 3+ million volume, there is something BIG going on..with the Implied VOlatality fluctuation and premium on options.

$HEPA Great pop in pre-market, has some good strength coming back after a big sell.

but that’s good for bios lately so after a morning dip $LABU goes higher taking us with it🤷 
go big blue!

Its definitely leaning towards a big run coming soon.

The volume today is going to activate alarm bells up &amp; down Wall Street and attract a lot of big money looking for a solid biotech investment. 🎉

$HEPA next leg up coming imo.. big news for a multi day run 🗞️

BIG props to our team of scientists, clinicians and entire team!! !

I can&#39;t stress enough how big a deal this is.

$HEPA deff see us making big $$$ at some point

Xeris Biopharma Holdings Inc

$XERS  This stock has become totally distorted by Wall Street manipulators!

In fact its just market manipulation by  shorts and rich assholes who use stocks like slot machines.

$XERS This stock is heavily MANIPULATED by a &quot;Gang of Shortsellers&quot; and has nothing to do with a fair market price!

It is so obvious this is being systematically walked down (manipulated) and has nothing to do with the Company itself, products, or the overall market.

Just goes to show how badly manipulated this is.

The manipulation of these criminals is unbelievable.

price

This Share Price is still 
 
Crazy  
 
Stupid  
 
Low. Cheers!

$XERS  This share price is crazy stupid low.

You’d think Paul would have some shame being below their price.

What is most disappointing about XERS, except for the collapse in stock price, is the failure of management to do much of anything to encourage retail or institutional investors to continue to have the confidence in management of the company or its future.

I think price targets are fake… there compensated to make targets IMO.

suck

Unfortunately, the mkt sucks now and that’s reflected in sp.

The whole market sucks and this has been unjustly hammered.

$XERS this is so fucked up its unbelievable.

Invested a lot of money , and realizing we are fucked.

What a crappy market! Hopefully next week will be better:)

$XERS A bad market must admit it is really a bad day.

$XERS A 10+ cent drop when you only have 14 of those until 0 ahead of all that gobbledygook fundamental longs are spouting is not a great sign of market confidence.

$XERS market on a year and this lame duck is flat or sinking

but unfortunately, in this market, not cheap either, and even less an outright buy without a very very strong conviction.

Market hinting something is terribly wrong with this company.

revenue

$XERS High risk is an understatement with XERS, weak drug lineup, weak pipeline, revenue grow slowing, cash burn increasing and worse than weak management should tell you to stay away.

Nothing positive, revenue continues to slow, spending increasing, generics coming, recorlev under performing and most important, incompetent management! !

Personally, I think this is very conservative, and comes in below the Strongbridge &quot;Low Case&quot; from page 87 of the merger prospectus because it comes out to $172M annual revenue in 2023 compared to $216M revenue on the prospectus.

Revenues are slowing, expenses are increasing, tech is marginal, patents will be expiring, pipeline is horrible and management is horrible.

but also very disappointing that my EV charger stocks have $Billion mkt caps with less than $50M revenue and years from cash flow positive and yet.

Not only are the current drugs low revenue producers and the pipeline is horrible.

.WS not impressed with 3 low revenue drugs and weak pipeline.

A Good Earnings Report along with Strong Forward Guidance might do it, as well as some good updates on the Tech Partnerships.

Two other drugs, each growing revenue steadily.

A levothyroxine formulation that looks positive (most commonly prescribed drug) A full proven technology platform to deliver hard to administer drugs by a simple injection.

Two (2) other drugs, each growing revenue steadily.

We have other amazing drugs, Recorlev, Gvoke and more including some drugs yet to be approved.

That said, I fully expect continuing  script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.

There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.

product

$XERS their primary product increases 9% week to week sales with an overall trend that&#39;s incredible.

$XERS I like their products and the inject opportunity with Horizon Tepezza is huge I wish they weren&#39;t acquired so they can keep a focus on that.

Earnings are growing and there could be great news any day from a variety of sources, whether a collab exercise of option, new product collab, royalty pmt, etc.

More important is that they grow Recorlev&#39;s revenue at high(er) speed, and continue to gain market share with Gvoke without product price drop.

Revenue exploding on the upside with
their 4 products.

Even if they have more short term gains coming soon, we know the Gvoke product will gain share back due to the more pleasant experience. Patience.

Gvoke is the best and easiest product out there.

Products have been approved and much more is coming, wait and relax.

For a tiny company like xeris to go toe to toe with lilly and grow share shows they have the best product.

$XERS Truly so strange, everything Xeris had in its programme has been met, briefly 3 FDA approved products, collaborations with major pharmacies and much, much more.

$XERS Good market yesterday, looking good today and good old XERS continues in the tank!!

but all of last week, in the middle of heavy market turmoil where we normally go down heavily, we stayed up and rose. Why?

Plenty of small caps were brought to lows (and thus made good buys) before starting recovery in this bear market, $ADMA, $ARAY, $PRTK, $CDTX, they all have turned or are turning around cause there is deep value and a clear path to profitability.

Top Stocks matching your search for "update drug"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Jan, 13, 2023

Jan, 11, 2023

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Jan, 6, 2023

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Jan, 13, 2023

Jan, 11, 2023

Dec, 28, 2022

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Jan, 6, 2023